TrialJournal of virology2006

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.

Iain Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.